Haemonetics Corporation (HAE)

NYSE: HAE · Real-Time Price · USD

78.78

+1.38 (1.78%)

Jul 24, 2026, 4:00 PM EDT - Market closed

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '26 Mar 28, 2026	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022	Apr '21 Apr 3, 2021	Mar '20 Mar 28, 2020	Mar '19 Mar 30, 2019	Mar '18 Mar 31, 2018	Apr '17 Apr 1, 2017	Apr '16 Apr 2, 2016	Mar '15 Mar 28, 2015	Mar '14 Mar 29, 2014	Mar '13 Mar 30, 2013
United States Revenue	982.18M	1.01B
Japan Revenue	68.20M	62.41M
Europe Revenue	185.02M	175.66M
Asia Revenue	87.21M	92.31M
Other Geographic Revenue	11.42M	19.54M
Revenue (Total)	1.33B	1.36B

Revenue Breakdown 2

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '26 Mar 28, 2026	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022	Apr '21 Apr 3, 2021	Mar '20 Mar 28, 2020	Mar '19 Mar 30, 2019	Mar '18 Mar 31, 2018	Apr '17 Apr 1, 2017	Apr '16 Apr 2, 2016	Mar '15 Mar 28, 2015	Mar '14 Mar 29, 2014	Mar '13 Mar 30, 2013
Plasma Revenue	524.46M	535.43M
Blood Center Revenue	221.27M	261.12M
Hospital Revenue	588.30M	564.27M
Revenue (Total)	1.33B	1.36B

EBIT

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '26 Mar 28, 2026	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022	Apr '21 Apr 3, 2021	Mar '20 Mar 28, 2020	Mar '19 Mar 30, 2019	Mar '18 Mar 31, 2018	Apr '17 Apr 1, 2017	Apr '16 Apr 2, 2016	Mar '15 Mar 28, 2015	Mar '14 Mar 29, 2014	Mar '13 Mar 30, 2013
Plasma Segment Operating Income (Post-Q3 2025 Reporting)	184.80M	184.51M
Blood Center Segment Operating Income (Post-Q3 2025 Reporting)	49.98M	52.82M
Hospital Segment Operating Income (Post-Q3 2025 Reporting)	103.74M	88.98M
Operating Income (Total)	156.73M	221.82M